(+)-dexrazoxane multiple interactions ISO RGD:10459 6480464 [Doxorubicin co-treated with Dexrazoxane] results in decreased expression of CYP7B1 mRNA CTD PMID:26873546 (2,4,5-trichlorophenoxy)acetic acid increases expression ISO RGD:10459 6480464 2 more ... CTD PMID:18579281 (25R)-cholest-5-ene-3beta,26-diol increases hydroxylation ISO RGD:735270 6480464 CYP7B1 protein results in increased hydroxylation of 27-hydroxycholesterol CTD PMID:10588945 (25R)-cholest-5-ene-3beta,26-diol increases metabolic processing ISO RGD:10459 6480464 CYP7B1 protein results in increased metabolism of 27-hydroxycholesterol CTD PMID:10748047 (25R)-cholest-5-ene-3beta,26-diol increases abundance ISO RGD:10459 6480464 CYP7B1 gene mutant form results in increased abundance of 27-hydroxycholesterol CTD PMID:10748047 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane affects expression ISO RGD:10459 6480464 o, p'-DDT affects the expression of CYP7B1 mRNA CTD PMID:18925944 1,1-dichloroethene decreases expression ISO RGD:10459 6480464 vinylidene chloride results in decreased expression of CYP7B1 mRNA CTD PMID:26682919 1,2-dimethylhydrazine increases expression ISO RGD:10459 6480464 1, 2-Dimethylhydrazine results in increased expression of CYP7B1 mRNA CTD PMID:22206623 1-naphthyl isothiocyanate decreases expression ISO RGD:10459 6480464 1-Naphthylisothiocyanate results in decreased expression of CYP7B1 mRNA CTD PMID:28549656 , PMID:30517764 1-naphthyl isothiocyanate multiple interactions ISO RGD:10459 6480464 [NR1H4 protein results in increased susceptibility to 1-Naphthylisothiocyanate] which results in decreased expression of CYP7B1 mRNA CTD PMID:29968724 17alpha-ethynylestradiol affects expression ISO RGD:10459 6480464 Ethinyl Estradiol affects the expression of CYP7B1 mRNA CTD PMID:17555576 17alpha-ethynylestradiol decreases expression ISO RGD:10459 6480464 Ethinyl Estradiol results in decreased expression of CYP7B1 mRNA, Ethinyl Estradiol results in decreased expression of CYP7B1 protein CTD PMID:34058177 17alpha-ethynylestradiol increases expression ISO RGD:10459 6480464 Ethinyl Estradiol results in increased expression of CYP7B1 mRNA CTD PMID:12072388 , PMID:16606610 17alpha-ethynylestradiol multiple interactions ISO RGD:10459 6480464 [Ethinyl Estradiol co-treated with Metformin] results in decreased expression of CYP7B1 mRNA, ESR1 protein promotes the reaction [Ethinyl Estradiol results in increased expression of CYP7B1 mRNA] CTD PMID:16606610 , PMID:34058177 17beta-estradiol decreases expression ISO RGD:735270 6480464 Estradiol results in decreased expression of CYP7B1 mRNA CTD PMID:16630558 17beta-estradiol multiple interactions EXP 6480464 [Testosterone co-treated with Estradiol] results in increased expression of CYP7B1 mRNA CTD PMID:32741896 17beta-estradiol increases expression ISO RGD:10459 6480464 Estradiol results in increased expression of CYP7B1 mRNA CTD PMID:19484750 , PMID:23144751 17beta-hydroxy-5alpha-androstan-3-one decreases activity ISO RGD:735270 6480464 Dihydrotestosterone results in decreased activity of CYP7B1 protein CTD PMID:16630558 17beta-hydroxy-5alpha-androstan-3-one decreases expression ISO RGD:735270 6480464 Dihydrotestosterone results in decreased expression of CYP7B1 mRNA CTD PMID:16630558 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of CYP7B1 mRNA CTD PMID:21215274 , PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of CYP7B1 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:10459 6480464 Tetrachlorodibenzodioxin results in decreased expression of CYP7B1 mRNA CTD PMID:28213091 , PMID:29452137 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:10459 6480464 Tetrachlorodibenzodioxin affects the expression of CYP7B1 mRNA CTD PMID:21570461 , PMID:28922406 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:10459 6480464 AHR gene mutant form inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of CYP7B1 mRNA] more ... CTD PMID:21846477 more ... 2,3,7,8-Tetrachlorodibenzofuran increases expression ISO RGD:10459 6480464 2 more ... CTD PMID:25768209 2-arachidonoylglycerol multiple interactions ISO RGD:10459 6480464 CNR1 gene mutant form inhibits the reaction [glyceryl 2-arachidonate results in increased expression of CYP7B1 mRNA] CTD PMID:23894352 2-arachidonoylglycerol increases expression ISO RGD:10459 6480464 glyceryl 2-arachidonate results in increased expression of CYP7B1 mRNA CTD PMID:23894352 25-hydroxycholesterol increases metabolic processing ISO RGD:10459 6480464 CYP7B1 protein results in increased metabolism of 25-hydroxycholesterol CTD PMID:10748047 25-hydroxycholesterol increases abundance ISO RGD:10459 6480464 CYP7B1 gene mutant form results in increased abundance of 25-hydroxycholesterol CTD PMID:10748047 26-hydroxycholesterol increases abundance ISO RGD:10459 6480464 CYP7B1 gene mutant form results in increased abundance of 27-hydroxycholesterol CTD PMID:10748047 26-hydroxycholesterol increases metabolic processing ISO RGD:10459 6480464 CYP7B1 protein results in increased metabolism of 27-hydroxycholesterol CTD PMID:10748047 26-hydroxycholesterol increases hydroxylation ISO RGD:735270 6480464 CYP7B1 protein results in increased hydroxylation of 27-hydroxycholesterol CTD PMID:10588945 3',5'-cyclic AMP decreases expression EXP 6480464 Cyclic AMP results in decreased expression of CYP7B1 mRNA CTD PMID:12029625 3',5'-cyclic AMP decreases activity EXP 6480464 Cyclic AMP results in decreased activity of CYP7B1 protein CTD PMID:12029625 3,3',5,5'-tetrabromobisphenol A decreases expression ISO RGD:10459 6480464 tetrabromobisphenol A results in decreased expression of CYP7B1 mRNA CTD PMID:25172293 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of CYP7B1 protein CTD PMID:34915118 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:735270 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of CYP7B1 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CYP7B1 mRNA CTD PMID:28628672 3H-1,2-dithiole-3-thione decreases expression ISO RGD:10459 6480464 1, 2-dithiol-3-thione results in decreased expression of CYP7B1 mRNA CTD PMID:15302862 4,4'-sulfonyldiphenol multiple interactions ISO RGD:735270 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of CYP7B1 mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol decreases methylation ISO RGD:735270 6480464 bis(4-hydroxyphenyl)sulfone results in decreased methylation of CYP7B1 gene CTD PMID:31601247 4-hydroxyphenyl retinamide increases expression ISO RGD:10459 6480464 Fenretinide results in increased expression of CYP7B1 mRNA CTD PMID:28973697 acetaldehyde affects expression ISO RGD:10459 6480464 Acetaldehyde affects the expression of CYP7B1 mRNA CTD PMID:22634333 aflatoxin B1 decreases expression ISO RGD:10459 6480464 Aflatoxin B1 results in decreased expression of CYP7B1 mRNA CTD PMID:19770486 aflatoxin B1 decreases expression ISO RGD:735270 6480464 Aflatoxin B1 results in decreased expression of CYP7B1 mRNA CTD PMID:27153756 aldrin increases expression ISO RGD:10459 6480464 Aldrin results in increased expression of CYP7B1 mRNA CTD PMID:18579281 AM-251 decreases expression ISO RGD:10459 6480464 AM 251 results in decreased expression of CYP7B1 mRNA CTD PMID:23894352 AM-251 multiple interactions ISO RGD:10459 6480464 AM 251 inhibits the reaction [Ethanol results in increased expression of CYP7B1 mRNA] CTD PMID:23894352 amiodarone decreases expression ISO RGD:10459 6480464 Amiodarone results in decreased expression of CYP7B1 mRNA CTD PMID:24535564 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of CYP7B1 mRNA CTD PMID:16483693 androstane-3,17-diol decreases expression ISO RGD:735270 6480464 Androstane-3, 17-diol results in decreased expression of CYP7B1 mRNA CTD PMID:16630558 arsane decreases expression ISO RGD:10459 6480464 Arsenic results in decreased expression of CYP7B1 mRNA CTD PMID:15026472 arsenic atom decreases expression ISO RGD:10459 6480464 Arsenic results in decreased expression of CYP7B1 mRNA CTD PMID:15026472 arsenous acid increases expression ISO RGD:735270 6480464 Arsenic Trioxide results in increased expression of CYP7B1 mRNA CTD PMID:17530438 , PMID:26705709 atazanavir sulfate multiple interactions ISO RGD:735270 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in decreased expression of CYP7B1 mRNA CTD PMID:33819548 atorvastatin calcium decreases expression ISO RGD:10459 6480464 Atorvastatin results in decreased expression of CYP7B1 mRNA CTD PMID:25278499 atrazine increases expression ISO RGD:10459 6480464 Atrazine results in increased expression of CYP7B1 mRNA CTD PMID:26775023 atrazine multiple interactions ISO RGD:10459 6480464 lycopene inhibits the reaction [Atrazine results in increased expression of CYP7B1 mRNA] CTD PMID:26775023 benzene increases expression ISO RGD:10459 6480464 Benzene results in increased expression of CYP7B1 mRNA CTD PMID:12928149 benzene multiple interactions ISO RGD:10459 6480464 TRP53 protein affects the reaction [Benzene results in increased expression of CYP7B1 mRNA] CTD PMID:12928149 benzo[a]pyrene affects expression ISO RGD:10459 6480464 Benzo(a)pyrene affects the expression of CYP7B1 mRNA CTD PMID:22342234 benzo[a]pyrene increases expression ISO RGD:10459 6480464 Benzo(a)pyrene results in increased expression of CYP7B1 protein CTD PMID:34472326 benzo[a]pyrene affects methylation ISO RGD:735270 6480464 Benzo(a)pyrene affects the methylation of CYP7B1 exon, Benzo(a)pyrene affects the methylation of CYP7B1 promoter CTD PMID:27901495 benzo[b]fluoranthene increases expression ISO RGD:10459 6480464 benzo(b)fluoranthene results in increased expression of CYP7B1 mRNA CTD PMID:26377693 benzo[e]pyrene increases methylation ISO RGD:735270 6480464 benzo(e)pyrene results in increased methylation of CYP7B1 intron CTD PMID:30157460 beta-naphthoflavone increases expression ISO RGD:735270 6480464 beta-Naphthoflavone results in increased expression of CYP7B1 mRNA CTD PMID:22258563 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:10459 6480464 Diethylhexyl Phthalate results in decreased expression of CYP7B1 mRNA CTD PMID:19245819 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of CYP7B1 mRNA CTD PMID:25181051 bisphenol A affects methylation ISO RGD:735270 6480464 bisphenol A affects the methylation of CYP7B1 gene CTD PMID:31601247 bisphenol A multiple interactions ISO RGD:735270 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CYP7B1 mRNA CTD PMID:28628672 bisphenol A decreases expression ISO RGD:10459 6480464 bisphenol A results in decreased expression of CYP7B1 mRNA CTD PMID:25594700 bisphenol F multiple interactions ISO RGD:735270 6480464 [bisphenol F co-treated with Fulvestrant] results in decreased methylation of CYP7B1 gene CTD PMID:31601247 cadmium dichloride decreases expression ISO RGD:10459 6480464 Cadmium Chloride results in decreased expression of CYP7B1 mRNA CTD PMID:11958953 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of CYP7B1 mRNA CTD PMID:25993096 caffeine decreases expression EXP 6480464 Caffeine results in decreased expression of CYP7B1 mRNA CTD PMID:20864626 calcitriol increases expression ISO RGD:735270 6480464 Calcitriol results in increased expression of CYP7B1 mRNA CTD PMID:26485663 carbon nanotube decreases expression ISO RGD:10459 6480464 Nanotubes more ... CTD PMID:25620056 carbon nanotube increases expression ISO RGD:10459 6480464 Nanotubes more ... CTD PMID:25554681 cefaloridine increases expression EXP 6480464 Cephaloridine results in increased expression of CYP7B1 mRNA CTD PMID:18500788 cerium trichloride increases expression ISO RGD:10459 6480464 cerous chloride results in increased expression of CYP7B1 mRNA CTD PMID:23139204 chenodeoxycholic acid multiple interactions ISO RGD:735270 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in decreased expression of CYP7B1 mRNA more ... CTD PMID:33819548 cholesterol increases activity EXP 6480464 Cholesterol results in increased activity of CYP7B1 protein CTD PMID:12029625 cholesterol increases expression EXP 6480464 Cholesterol results in increased expression of CYP7B1 mRNA CTD PMID:12029625 cholic acid decreases expression ISO RGD:10459 6480464 Cholic Acid results in decreased expression of CYP7B1 mRNA CTD PMID:20671298 choline multiple interactions ISO RGD:10459 6480464 [Choline deficiency co-treated with Folic Acid deficiency co-treated with Methionine deficiency] results in decreased expression of CYP7B1 mRNA, [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of CYP7B1 mRNA CTD PMID:22872676 , PMID:29127188 ciprofibrate decreases expression ISO RGD:10459 6480464 ciprofibrate results in decreased expression of CYP7B1 mRNA CTD PMID:12771043 clofibrate decreases expression ISO RGD:10459 6480464 Clofibrate results in decreased expression of CYP7B1 mRNA CTD PMID:17585979 , PMID:28973556 copper atom increases expression ISO RGD:10459 6480464 Copper results in increased expression of CYP7B1 mRNA CTD PMID:17205981 copper(0) increases expression ISO RGD:10459 6480464 Copper results in increased expression of CYP7B1 mRNA CTD PMID:17205981 copper(II) sulfate increases expression ISO RGD:10459 6480464 Copper Sulfate results in increased expression of CYP7B1 mRNA CTD PMID:18579281 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of CYP7B1 mRNA CTD PMID:26577399 cyclosporin A decreases expression ISO RGD:10459 6480464 Cyclosporine results in decreased expression of CYP7B1 mRNA CTD PMID:19770486 cyclosporin A multiple interactions ISO RGD:735270 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Cyclosporine] results in decreased expression of CYP7B1 mRNA CTD PMID:33819548 dehydroepiandrosterone increases hydroxylation ISO RGD:735270 6480464 CYP7B1 protein results in increased hydroxylation of Dehydroepiandrosterone CTD PMID:10588945 deoxycholic acid multiple interactions ISO RGD:10459 6480464 SLCO1A1 protein affects the susceptibility to [Deoxycholic Acid results in decreased expression of CYP7B1 mRNA] CTD PMID:21914718 deoxycholic acid multiple interactions ISO RGD:735270 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in decreased expression of CYP7B1 mRNA more ... CTD PMID:33819548 deoxycholic acid decreases expression ISO RGD:10459 6480464 Deoxycholic Acid results in decreased expression of CYP7B1 mRNA CTD PMID:21914718 , PMID:25582706 dexamethasone multiple interactions ISO RGD:735270 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of CYP7B1 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CYP7B1 mRNA CTD PMID:28628672 dextran sulfate multiple interactions ISO RGD:10459 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CYP7B1 mRNA CTD PMID:29950665 diarsenic trioxide increases expression ISO RGD:735270 6480464 Arsenic Trioxide results in increased expression of CYP7B1 mRNA CTD PMID:17530438 , PMID:26705709 dibenz[a,h]anthracene increases expression ISO RGD:10459 6480464 1 more ... CTD PMID:26377693 dichloroacetic acid decreases expression ISO RGD:10459 6480464 Dichloroacetic Acid results in decreased expression of CYP7B1 mRNA CTD PMID:28962523 dimethylarsinic acid increases expression ISO RGD:10459 6480464 Cacodylic Acid results in increased expression of CYP7B1 mRNA CTD PMID:17441966 dimethylarsinic acid multiple interactions ISO RGD:10459 6480464 OGG1 protein inhibits the reaction [Cacodylic Acid results in increased expression of CYP7B1 mRNA] CTD PMID:17441966 dioxygen multiple interactions ISO RGD:10459 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CYP7B1 mRNA CTD PMID:30529165 doxorubicin multiple interactions ISO RGD:10459 6480464 [Doxorubicin co-treated with Dexrazoxane] results in decreased expression of CYP7B1 mRNA CTD PMID:26873546 elemental selenium increases expression ISO RGD:10459 6480464 Selenium deficiency results in increased expression of CYP7B1 mRNA, Selenium results in increased expression of CYP7B1 mRNA CTD PMID:16170372 emodin decreases expression ISO RGD:10459 6480464 Emodin results in decreased expression of CYP7B1 mRNA CTD PMID:30517764 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of CYP7B1 mRNA CTD PMID:29391264 enilconazole decreases expression ISO RGD:735270 6480464 enilconazole results in decreased expression of CYP7B1 mRNA CTD PMID:32201337 ethanol decreases expression EXP 6480464 Ethanol results in decreased expression of CYP7B1 mRNA CTD PMID:15353170 ethanol increases expression ISO RGD:10459 6480464 Ethanol results in increased expression of CYP7B1 mRNA CTD PMID:23894352 ethanol multiple interactions ISO RGD:10459 6480464 AM 251 inhibits the reaction [Ethanol results in increased expression of CYP7B1 mRNA] CTD PMID:23894352 fenofibrate multiple interactions EXP 6480464 [Fenofibrate co-treated with Diethylnitrosamine] results in decreased expression of CYP7B1 mRNA CTD PMID:18253720 flumequine multiple interactions ISO RGD:10459 6480464 [flumequine co-treated with 2-amino-3 more ... CTD PMID:23681119 flusilazole affects expression ISO RGD:10459 6480464 flusilazole affects the expression of CYP7B1 mRNA CTD PMID:22634333 folic acid multiple interactions ISO RGD:10459 6480464 [Choline deficiency co-treated with Folic Acid deficiency co-treated with Methionine deficiency] results in decreased expression of CYP7B1 mRNA, [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of CYP7B1 mRNA CTD PMID:22872676 , PMID:29127188 fulvestrant multiple interactions ISO RGD:735270 6480464 [bisphenol F co-treated with Fulvestrant] results in decreased methylation of CYP7B1 gene CTD PMID:31601247 fumonisin B1 multiple interactions ISO RGD:10459 6480464 [NR1H2 protein affects the susceptibility to fumonisin B1] which affects the expression of CYP7B1 mRNA, [NR1H3 protein affects the susceptibility to fumonisin B1] which affects the expression of CYP7B1 mRNA CTD PMID:30448865 furan increases expression EXP 6480464 furan results in increased expression of CYP7B1 mRNA CTD PMID:27387713 glycochenodeoxycholic acid multiple interactions ISO RGD:735270 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in decreased expression of CYP7B1 mRNA more ... CTD PMID:33819548 glycocholic acid multiple interactions ISO RGD:735270 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in decreased expression of CYP7B1 mRNA more ... CTD PMID:33819548 glycodeoxycholic acid multiple interactions ISO RGD:735270 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in decreased expression of CYP7B1 mRNA more ... CTD PMID:33819548 griseofulvin decreases expression ISO RGD:10459 6480464 Griseofulvin results in decreased expression of CYP7B1 mRNA CTD PMID:12735108 hexachlorobenzene increases expression EXP 6480464 Hexachlorobenzene results in increased expression of CYP7B1 mRNA CTD PMID:15159207 indole-3-methanol affects expression EXP 6480464 indole-3-carbinol affects the expression of CYP7B1 mRNA CTD PMID:21396975 indometacin multiple interactions ISO RGD:735270 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of CYP7B1 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CYP7B1 mRNA CTD PMID:28628672 L-methionine multiple interactions ISO RGD:10459 6480464 [Choline deficiency co-treated with Folic Acid deficiency co-treated with Methionine deficiency] results in decreased expression of CYP7B1 mRNA, [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of CYP7B1 mRNA CTD PMID:22872676 , PMID:29127188 lipopolysaccharide multiple interactions ISO RGD:735270 6480464 [S-(1 more ... CTD PMID:28070326 , PMID:35811015 lipopolysaccharide increases expression ISO RGD:735270 6480464 Lipopolysaccharides results in increased expression of CYP7B1 mRNA CTD PMID:35811015 lipopolysaccharide affects expression ISO RGD:735270 6480464 Lipopolysaccharides affects the expression of CYP7B1 mRNA CTD PMID:28070326 lithocholic acid decreases expression ISO RGD:10459 6480464 Lithocholic Acid results in decreased expression of CYP7B1 mRNA CTD PMID:19196849 lithocholic acid multiple interactions ISO RGD:10459 6480464 1 more ... CTD PMID:19196849 lycopene multiple interactions ISO RGD:10459 6480464 lycopene inhibits the reaction [Atrazine results in increased expression of CYP7B1 mRNA] CTD PMID:26775023 MeIQx multiple interactions ISO RGD:10459 6480464 [flumequine co-treated with 2-amino-3 more ... CTD PMID:23681119 metacetamol decreases expression ISO RGD:10459 6480464 3-hydroxyacetanilide results in decreased expression of CYP7B1 mRNA CTD PMID:18544908 metformin multiple interactions ISO RGD:10459 6480464 [Ethinyl Estradiol co-treated with Metformin] results in decreased expression of CYP7B1 mRNA CTD PMID:34058177 methamphetamine decreases expression ISO RGD:10459 6480464 Methamphetamine results in decreased expression of CYP7B1 mRNA CTD PMID:35688268 methapyrilene increases methylation ISO RGD:735270 6480464 Methapyrilene results in increased methylation of CYP7B1 intron CTD PMID:30157460 methoxyacetic acid decreases expression EXP 6480464 methoxyacetic acid results in decreased expression of CYP7B1 mRNA CTD PMID:20864626 methylmercury chloride decreases expression EXP 6480464 methylmercuric chloride results in decreased expression of CYP7B1 mRNA CTD PMID:20864626 Monobutylphthalate decreases expression EXP 6480464 monobutyl phthalate results in decreased expression of CYP7B1 mRNA CTD PMID:20864626 N-nitrosodiethylamine decreases expression ISO RGD:10459 6480464 Diethylnitrosamine results in decreased expression of CYP7B1 mRNA CTD PMID:12771043 N-nitrosodiethylamine multiple interactions EXP 6480464 [Fenofibrate co-treated with Diethylnitrosamine] results in decreased expression of CYP7B1 mRNA CTD PMID:18253720 nefazodone multiple interactions ISO RGD:735270 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in decreased expression of CYP7B1 mRNA CTD PMID:33819548 nickel atom increases expression ISO RGD:735270 6480464 Nickel results in increased expression of CYP7B1 mRNA CTD PMID:24768652 , PMID:25583101 O-methyleugenol decreases expression ISO RGD:735270 6480464 methyleugenol results in decreased expression of CYP7B1 mRNA CTD PMID:32234424 oleanolic acid decreases expression ISO RGD:10459 6480464 Oleanolic Acid results in decreased expression of CYP7B1 mRNA CTD PMID:23948738 ozone decreases expression ISO RGD:10459 6480464 Ozone results in decreased expression of CYP7B1 mRNA CTD PMID:16183385 ozone multiple interactions ISO RGD:10459 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of CYP7B1 mRNA more ... CTD PMID:25658374 , PMID:34911549 ozone increases expression ISO RGD:10459 6480464 Ozone results in increased expression of CYP7B1 mRNA CTD PMID:21543283 paracetamol decreases expression ISO RGD:10459 6480464 Acetaminophen results in decreased expression of CYP7B1 mRNA CTD PMID:18544908 , PMID:29246445 paracetamol multiple interactions ISO RGD:735270 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of CYP7B1 mRNA CTD PMID:33819548 paracetamol decreases expression ISO RGD:735270 6480464 Acetaminophen results in decreased expression of CYP7B1 mRNA CTD PMID:29067470 paracetamol multiple interactions ISO RGD:10459 6480464 PANX1 gene mutant form inhibits the reaction [Acetaminophen results in decreased expression of CYP7B1 mRNA], YAP1 gene mutant form promotes the reaction [Acetaminophen results in increased expression of CYP7B1 mRNA] CTD PMID:29246445 , PMID:34546377 paracetamol affects expression ISO RGD:10459 6480464 Acetaminophen affects the expression of CYP7B1 mRNA CTD PMID:17562736 paraquat increases expression EXP 6480464 Paraquat results in increased expression of CYP7B1 mRNA CTD PMID:32680482 perfluorononanoic acid decreases expression ISO RGD:10459 6480464 perfluoro-n-nonanoic acid results in decreased expression of CYP7B1 mRNA CTD PMID:29112762 perfluorooctane-1-sulfonic acid affects expression ISO RGD:10459 6480464 perfluorooctane sulfonic acid affects the expression of CYP7B1 mRNA CTD PMID:19429403 perfluorooctanoic acid affects expression ISO RGD:10459 6480464 perfluorooctanoic acid affects the expression of CYP7B1 mRNA CTD PMID:19429403 phenobarbital multiple interactions ISO RGD:10459 6480464 NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of CYP7B1 mRNA] more ... CTD PMID:19196849 , PMID:19482888 phenobarbital increases expression ISO RGD:735270 6480464 Phenobarbital results in increased expression of CYP7B1 mRNA CTD PMID:22258563 phenobarbital decreases expression ISO RGD:10459 6480464 Phenobarbital results in decreased expression of CYP7B1 mRNA CTD PMID:19482888 , PMID:23091169 phenobarbital affects expression ISO RGD:10459 6480464 Phenobarbital affects the expression of CYP7B1 mRNA CTD PMID:19136022 phenytoin increases expression EXP 6480464 Phenytoin results in increased expression of CYP7B1 mRNA CTD PMID:20345932 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:10459 6480464 [sodium arsenite co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of CYP7B1 mRNA CTD PMID:16368122 phorbol 13-acetate 12-myristate decreases expression EXP 6480464 Tetradecanoylphorbol Acetate results in decreased expression of CYP7B1 mRNA CTD PMID:12029625 phorbol 13-acetate 12-myristate decreases activity EXP 6480464 Tetradecanoylphorbol Acetate results in decreased activity of CYP7B1 protein CTD PMID:12029625 phytosterols multiple interactions ISO RGD:10459 6480464 APOE gene mutant form affects the reaction [Phytosterols results in increased expression of CYP7B1 mRNA] CTD PMID:18155511 piperonyl butoxide decreases expression ISO RGD:10459 6480464 Piperonyl Butoxide results in decreased expression of CYP7B1 mRNA CTD PMID:30572783 pirinixic acid multiple interactions ISO RGD:10459 6480464 [pirinixic acid co-treated with PPARA] results in decreased expression of CYP7B1 mRNA, PPARA protein promotes the reaction [pirinixic acid results in decreased expression of CYP7B1 mRNA] CTD PMID:20059764 , PMID:20813756 pirinixic acid decreases expression ISO RGD:10459 6480464 pirinixic acid results in decreased expression of CYP7B1 mRNA CTD PMID:15302862 more ... pirinixic acid affects expression ISO RGD:10459 6480464 pirinixic acid affects the expression of CYP7B1 mRNA CTD PMID:19136022 pregnenolone 16alpha-carbonitrile decreases expression EXP 6480464 Pregnenolone Carbonitrile results in decreased expression of CYP7B1 mRNA CTD PMID:19162173 propiconazole decreases expression EXP 6480464 propiconazole results in decreased expression of CYP7B1 mRNA CTD PMID:19423681 resveratrol multiple interactions ISO RGD:10459 6480464 Resveratrol inhibits the reaction [titanium dioxide results in decreased expression of CYP7B1 mRNA] CTD PMID:31298478 rifaximin multiple interactions ISO RGD:735270 6480464 [NR1I2 results in increased susceptibility to rifaximin] which results in increased expression of CYP7B1 protein CTD PMID:22790967 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of CYP7B1 mRNA CTD PMID:28374803 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:735270 6480464 [S-(1 more ... CTD PMID:35811015 selenium atom increases expression ISO RGD:10459 6480464 Selenium deficiency results in increased expression of CYP7B1 mRNA, Selenium results in increased expression of CYP7B1 mRNA CTD PMID:16170372 sodium arsenate decreases expression ISO RGD:10459 6480464 sodium arsenate results in decreased expression of CYP7B1 mRNA CTD PMID:11353140 sodium arsenite decreases expression ISO RGD:10459 6480464 sodium arsenite results in decreased expression of CYP7B1 mRNA CTD PMID:14691202 sodium arsenite affects methylation ISO RGD:735270 6480464 sodium arsenite affects the methylation of CYP7B1 gene CTD PMID:28589171 sodium arsenite multiple interactions ISO RGD:10459 6480464 [sodium arsenite co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of CYP7B1 mRNA CTD PMID:16368122 sodium arsenite affects expression ISO RGD:10459 6480464 sodium arsenite affects the expression of CYP7B1 mRNA CTD PMID:16507464 Soman increases expression EXP 6480464 Soman results in increased expression of CYP7B1 mRNA CTD PMID:19281266 streptozocin multiple interactions ISO RGD:10459 6480464 [Dietary Fats co-treated with Streptozocin] results in decreased expression of CYP7B1 mRNA, [Streptozocin co-treated with Dietary Fats] results in decreased expression of CYP7B1 mRNA CTD PMID:29127188 , PMID:29382564 succimer multiple interactions ISO RGD:10459 6480464 [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CYP7B1 mRNA CTD PMID:26378955 sunitinib decreases expression ISO RGD:735270 6480464 Sunitinib results in decreased expression of CYP7B1 mRNA CTD PMID:31533062 Sunset Yellow FCF multiple interactions ISO RGD:735270 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in decreased expression of CYP7B1 mRNA CTD PMID:33819548 tamoxifen affects expression ISO RGD:10459 6480464 Tamoxifen affects the expression of CYP7B1 mRNA CTD PMID:17555576 tartrazine multiple interactions ISO RGD:735270 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of CYP7B1 mRNA CTD PMID:33819548 taurocholic acid decreases activity EXP 6480464 Taurocholic Acid results in decreased activity of CYP7B1 protein CTD PMID:12029625 taurocholic acid decreases expression EXP 6480464 Taurocholic Acid results in decreased expression of CYP7B1 mRNA CTD PMID:12029625 taurodeoxycholic acid decreases activity EXP 6480464 Taurodeoxycholic Acid results in decreased activity of CYP7B1 protein CTD PMID:12029625 taurodeoxycholic acid decreases expression EXP 6480464 Taurodeoxycholic Acid results in decreased expression of CYP7B1 mRNA CTD PMID:12029625 testosterone increases expression ISO RGD:10459 6480464 Testosterone results in increased expression of CYP7B1 mRNA CTD PMID:20844152 , PMID:21669218 testosterone multiple interactions EXP 6480464 [Testosterone co-treated with Estradiol] results in increased expression of CYP7B1 mRNA CTD PMID:32741896 tetrachloromethane increases expression ISO RGD:10459 6480464 Carbon Tetrachloride results in increased expression of CYP7B1 mRNA CTD PMID:17484886 tetrachloromethane decreases expression ISO RGD:10459 6480464 Carbon Tetrachloride results in decreased expression of CYP7B1 mRNA CTD PMID:27339419 more ... tetracycline decreases expression ISO RGD:10459 6480464 Tetracycline results in decreased expression of CYP7B1 mRNA CTD PMID:24489787 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of CYP7B1 mRNA CTD PMID:26222700 titanium dioxide increases expression ISO RGD:10459 6480464 titanium dioxide results in increased expression of CYP7B1 mRNA CTD PMID:23557971 , PMID:27760801 titanium dioxide multiple interactions ISO RGD:10459 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CYP7B1 mRNA, Resveratrol inhibits the reaction [titanium dioxide results in decreased expression of CYP7B1 mRNA] CTD PMID:29950665 , PMID:31298478 titanium dioxide decreases expression ISO RGD:10459 6480464 titanium dioxide results in decreased expression of CYP7B1 mRNA CTD PMID:31298478 trichloroethene decreases expression ISO RGD:10459 6480464 Trichloroethylene results in decreased expression of CYP7B1 mRNA CTD PMID:25549359 urethane increases expression ISO RGD:735270 6480464 Urethane results in increased expression of CYP7B1 mRNA CTD PMID:28818685 ursodeoxycholic acid decreases expression ISO RGD:10459 6480464 Ursodeoxycholic Acid results in decreased expression of CYP7B1 mRNA CTD PMID:20671298 valproic acid decreases expression ISO RGD:10459 6480464 Valproic Acid results in decreased expression of CYP7B1 mRNA CTD PMID:24535564 zaragozic acid A decreases activity EXP 6480464 squalestatin 1 results in decreased activity of CYP7B1 protein CTD PMID:12029625 zaragozic acid A decreases expression EXP 6480464 squalestatin 1 results in decreased expression of CYP7B1 mRNA CTD PMID:12029625